S Schryber

535 total citations
9 papers, 435 citations indexed

About

S Schryber is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, S Schryber has authored 9 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in S Schryber's work include Cancer Treatment and Pharmacology (5 papers), Acute Myeloid Leukemia Research (2 papers) and Neutropenia and Cancer Infections (2 papers). S Schryber is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Acute Myeloid Leukemia Research (2 papers) and Neutropenia and Cancer Infections (2 papers). S Schryber collaborates with scholars based in United States and Germany. S Schryber's co-authors include Joseph P. Eder, Karen H. Antman, W. David Henner, Lowell E. Schnipper, W. P. Peters, Anthony Elias, Robert W. Finberg, M. Tracie Shea, Thomas C. Shea and D. W. Wilmore and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Clinical Science.

In The Last Decade

S Schryber

9 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S Schryber United States	8	258	143	107	82	77	9	435
Marwan Yared United States	12	176 0.7×	90 0.6×	74 0.7×	192 2.3×	53 0.7×	20	523
Franco Testore Italy	11	513 2.0×	60 0.4×	113 1.1×	53 0.6×	145 1.9×	20	673
K.N. Price Switzerland	10	294 1.1×	77 0.5×	256 2.4×	51 0.6×	201 2.6×	19	597
M. Varini Switzerland	11	319 1.2×	62 0.4×	201 1.9×	240 2.9×	184 2.4×	18	646
Mason Bond Canada	11	122 0.5×	99 0.7×	40 0.4×	57 0.7×	196 2.5×	15	510
Peter Bojko Germany	13	181 0.7×	265 1.9×	33 0.3×	43 0.5×	58 0.8×	37	523
E. Heidemann Germany	12	509 2.0×	65 0.5×	111 1.0×	433 5.3×	155 2.0×	42	793
C C Zielinski Austria	13	266 1.0×	38 0.3×	56 0.5×	137 1.7×	201 2.6×	25	570
Kristín Bjarnadóttir Iceland	5	166 0.6×	54 0.4×	82 0.8×	61 0.7×	38 0.5×	8	335
Kennedy Bj United States	12	115 0.4×	74 0.5×	57 0.5×	55 0.7×	129 1.7×	36	563

Countries citing papers authored by S Schryber

Since Specialization

Citations

This map shows the geographic impact of S Schryber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Schryber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Schryber more than expected).

Fields of papers citing papers by S Schryber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Schryber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Schryber. The network helps show where S Schryber may publish in the future.

Co-authorship network of co-authors of S Schryber

This figure shows the co-authorship network connecting the top 25 collaborators of S Schryber. A scholar is included among the top collaborators of S Schryber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Schryber. S Schryber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Elias, Anthony, Lois Ayash, Joseph P. Eder, et al.. (1991). A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.. Journal of Clinical Oncology. 9(2). 320–327. 39 indexed citations

Eder, Joseph P., Anthony Elias, Thomas C. Shea, et al.. (1990). A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.. Journal of Clinical Oncology. 8(7). 1239–1245. 67 indexed citations

Antman, Karen H., Joseph P. Eder, Alby Elias, et al.. (1990). High-dose thiotepa alone and in combination regimens with bone marrow support.. PubMed. 17(1 Suppl 3). 33–8. 30 indexed citations

Graves, Steven W., et al.. (1989). Endogenous Digoxin-Like Immunoreactive Factor and Digitalislike Factor Associated with the Hypertension of Patients Receiving Multiple Alkylating Agents as Part of Autologous Bone Marrow Transplantation. Clinical Science. 77(5). 501–507. 14 indexed citations

Eder, Joseph P., Karen H. Antman, Anthony Elias, et al.. (1988). Cyclophosphamide and Thiotepa With Autologous Bone Marrow Transplantation in Patients With Solid Tumors. JNCI Journal of the National Cancer Institute. 80(15). 1221–1226. 42 indexed citations

Antman, Karen H., Joseph P. Eder, Alby Elias, et al.. (1987). High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.. PubMed. 71(2). 119–25. 37 indexed citations

Eder, Joseph P., Karen H. Antman, W. P. Peters, et al.. (1986). High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.. Journal of Clinical Oncology. 4(11). 1592–1597. 103 indexed citations

Eder, Joseph P., Robert C. Bast, William P. Peters, et al.. (1986). Prediction of the optimal timing of bone marrow reinfusion after high dose chemotherapy.. PubMed. 46(9). 4496–9. 7 indexed citations

Peters, W. P., Joseph P. Eder, W. David Henner, et al.. (1986). High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.. Journal of Clinical Oncology. 4(5). 646–654. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact